In conclusion, CEACAM6 as detected by AP11, may serve as a marker for mucin-producing adenocarcinomas of the gastrointestinal tract and ovary as well as non-small cell lung cancer. This evidence concerns the gene MUC5AC and non-small cell lung carcinoma.